UK Specific Documents

At Orphalan we identify, develop and provide access to innovative treatments for patients with rare diseases.

Modern Slavery Statement

Orphalan UK Ltd. has taken steps to understand all potential modern slavery risks related to its business, in accordance with Section 54 of the UK Modern Slavery Act 2015.

We are committed to preventing slavery and human trafficking, both in our own corporate activities and our supply chain. We take measures to ensure that all of our contractors, suppliers and business partners comply with the same high standards.

Click here to view the PDF.

Carbon Reduction Plan (CRP)

Orphalan UK is committed to achieving Net Zero emissions by 2045. Click here to access the report.

Working with Patient Organisations and Members of the Public

Orphalan UK is committed to ensuring any interactions between the pharmaceutical industry and healthcare professionals (HCP), healthcare organisations (HCO) and patient organisations (PO) meet the high standards of professionalism, integrity and transparency that are expected.

Click here to view Disclosure Methodological note 2025.
Click here to view Working with Patient Organisations and Members of the Public, disclosure template 2025.